Latest Conference Articles

Asking the Right Questions as a Patient With Breast Cancer

Asking the Right Questions as a Patient With Breast Cancer

March 8th 2020, 10:00pm

Miami Breast Cancer Conference and Educated Patient Breast Cancer Summit

At the 2020 CURE® Educated Patient Breast Cancer Summit, oncology nurse Patricia Jakel had the chance to discuss the types of questions patients should be asking their care team.

Becoming Your Own Best Advocate and Building a Dream Team to Thrive

Becoming Your Own Best Advocate and Building a Dream Team to Thrive

March 8th 2020, 8:00pm

Miami Breast Cancer Conference and Educated Patient Breast Cancer Summit

At CURE’s Educated Patient Breast Cancer Summit, Stephanie Seban shared the ways a patient can become their own best advocate to thrive through their breast cancer journey.

Educating Patients, and Physicians, On the Importance of Genetic Testing In Breast Cancer

Educating Patients, and Physicians, On the Importance of Genetic Testing In Breast Cancer

March 8th 2020, 6:00pm

Miami Breast Cancer Conference and Educated Patient Breast Cancer Summit

Genetic and genomic testing is vital for patients with breast cancer and not only do patients need to understand why that is, but their physicians as well.

Exercise Programs Improve Outcomes for Patients with Breast Cancer

Exercise Programs Improve Outcomes for Patients with Breast Cancer

March 8th 2020, 12:39am

Miami Breast Cancer Conference and Educated Patient Breast Cancer Summit

At the 37th Annual Miami Breast Cancer Conference Dr. Jean-Bernard Durand discussed data that showed how prescribed and personalized exercise programs can improve outcomes for patients with cancer who already face a high risk of cardiovascular disease.

Survivorship Starts at Diagnosis: How Doctors Can Better Understand

Survivorship Starts at Diagnosis: How Doctors Can Better Understand

March 7th 2020, 10:00pm

Miami Breast Cancer Conference and Educated Patient Breast Cancer Summit

“A person becomes a survivor from the point they are diagnosed and for the balance of their lives,” Dr. Don S. Dizon said in a presentation at the 37th Annual Miami Breast Cancer Conference®.

Expert Highlights Need for New Paradigm in Genetic Testing

Expert Highlights Need for New Paradigm in Genetic Testing

March 7th 2020, 8:00pm

Miami Breast Cancer Conference and Educated Patient Breast Cancer Summit

At the 37th Annual Miami Breast Cancer Conference, Dr. Kevin S. Hughes discussed genetic testing and what health care providers should be doing to identify more individuals at risk for cancer.

Xentuzumab Combination Shows Promise in Advanced Breast Cancer

Xentuzumab Combination Shows Promise in Advanced Breast Cancer

March 7th 2020, 1:06am

Miami Breast Cancer Conference and Educated Patient Breast Cancer Summit

Xentuzumab in combination with Verzenio, with or without endocrine therapy, may be safe and effective in treating patients with solid tumors and advanced breast cancer.

MONALEESA-7 Trial Follow-Up Shows Maintained, Improved Quality of Life, Work Productivity

MONALEESA-7 Trial Follow-Up Shows Maintained, Improved Quality of Life, Work Productivity

March 6th 2020, 11:00pm

Miami Breast Cancer Conference and Educated Patient Breast Cancer Summit

Premenopausal women with HR-positive, HER2-negative advanced breast cancer experienced improved survival and quality of life with the addition of Kisqali to Zoladex and endocrine therapy to their treatment regimen.

Study Finds No Difference in Psychosocial Scores Following Contralateral Mastectomy

Study Finds No Difference in Psychosocial Scores Following Contralateral Mastectomy

March 6th 2020, 7:13pm

Miami Breast Cancer Conference and Educated Patient Breast Cancer Summit

Women who had contralateral prophylactic mastectomy reported similar breast satisfaction and quality of life, cancer-related distress and anxiety and depression scores, compared with those who did not undergo the procedure.

Understanding the Key Aspects of a Multiple Myeloma Diagnosis

Understanding the Key Aspects of a Multiple Myeloma Diagnosis

January 3rd 2020, 3:00am

Educated Patient® Multiple Myeloma Summit

A multiple myeloma expert helps newly diagnosed patients understand the standard of care for their disease.

Precision Medicine Paves the Way for Exciting Treatment Combinations for Patients with Multiple Myeloma

Precision Medicine Paves the Way for Exciting Treatment Combinations for Patients with Multiple Myeloma

December 25th 2019, 2:00am

Educated Patient® Multiple Myeloma Summit

Patients with multiple myeloma have a lot to look forward to in the treatment space thanks to precision medicine, but one treatment option alone will not cure the disease.

MDM2 Inhibitor Shows Promise For Patients With AML

MDM2 Inhibitor Shows Promise For Patients With AML

December 24th 2019, 12:00am

American Society of Hematology Annual Meeting

New findings show that a wider study is needed for MDM2 inhibitors in treating patients with AML.

Coming to Grips with A Multiple Myeloma Diagnosis

Coming to Grips with A Multiple Myeloma Diagnosis

December 21st 2019, 3:00am

Educated Patient® Multiple Myeloma Summit

At the 2019 CURE® Educated Patient® Summit on Multiple Myeloma patient advocate and 10-year survivor Terry White had the chance to share advice on handling a cancer diagnosis.

Addressing Questions From Newly Diagnosed Patients with Multiple Myeloma

Addressing Questions From Newly Diagnosed Patients with Multiple Myeloma

December 20th 2019, 3:00am

Educated Patient® Multiple Myeloma Summit

Naturally, newly diagnosed patients with multiple myeloma have a lot of questions for their physicians. Dr. Joshua Richter had the time to discuss some of them.

Real-World Data Shows Promise for Patients on CAR-T Therapy

Real-World Data Shows Promise for Patients on CAR-T Therapy

December 20th 2019, 12:00am

American Society of Hematology Annual Meeting

Real-world data shows that CAR-T therapy can lower costs for patients with pre-existing comorbidities outside of the clinical setting.

Oral Paclitaxel Improves Response, Reduces Peripheral Neuropathy in Metastatic Breast Cancer

Oral Paclitaxel Improves Response, Reduces Peripheral Neuropathy in Metastatic Breast Cancer

December 18th 2019, 6:57pm

SABCS

Patients with metastatic breast cancer who received an oral version of the chemotherapy drug experienced improved response rates and reductions in peripheral neuropathy compared to those who took the drug intravenously.

Men with Breast Cancer Must Attend Major Conferences to Advocate for Themselves

Men with Breast Cancer Must Attend Major Conferences to Advocate for Themselves

December 18th 2019, 3:00am

SABCS

At the 2019 San Antonio Breast Cancer Symposium, Khevin Barnes advocated on behalf of men with breast cancer, but also advocated for more men with breast cancer to join him.

Circulating Tumor DNA After Neoadjuvant Chemo May Determine Risk of Recurrence in TNBC

Circulating Tumor DNA After Neoadjuvant Chemo May Determine Risk of Recurrence in TNBC

December 18th 2019, 1:00am

SABCS

Patients with early-stage triple-negative breast cancer who did not have circulating tumor DNA in their blood experienced superior outcomes to chemotherapy followed by surgery.

Measuring Residual Cancer Burden Could Help Improve Predictions of Breast Cancer Outcomes

Measuring Residual Cancer Burden Could Help Improve Predictions of Breast Cancer Outcomes

December 16th 2019, 7:17pm

SABCS

Residual cancer burden can help physicians pinpoint accurate long-term predictions about the likelihood that a patient’s breast cancer will return.

Understanding the Role of Immunoglobulins in Multiple Myeloma

Understanding the Role of Immunoglobulins in Multiple Myeloma

December 16th 2019, 12:52am

Educated Patient® Multiple Myeloma Summit

At CURE’s Educated Patient Summit on Multiple Myeloma Dr. Shebli Atrash had the chance to further discuss with CURE what questions he addresses most when patients with multiple myeloma undergo diagnostic testing.

MRD Measurement Shows Promise for Making Informed Treatment Decisions in Myeloma

MRD Measurement Shows Promise for Making Informed Treatment Decisions in Myeloma

December 15th 2019, 9:57pm

Educated Patient® Multiple Myeloma Summit

At CURE’s Educated Patient Summit on Multiple Myeloma, Dr. Barry Paul discussed the role of minimal residual disease measurement and how it may be used in the future to determine treatment options for patients with myeloma.

Patients with Multiple Myeloma Give Themselves Hope Through Treatment

Patients with Multiple Myeloma Give Themselves Hope Through Treatment

December 15th 2019, 2:11am

Educated Patient® Multiple Myeloma Summit

Dr. Cesar Rodriguez offers a message of hope and self-determination for patients with multiple myeloma.

Menopausal Hormone Therapy with Estrogen Alone Decreases Breast Cancer Incidence

Menopausal Hormone Therapy with Estrogen Alone Decreases Breast Cancer Incidence

December 14th 2019, 12:00am

SABCS

Women who took estrogen alone as hormone therapy for their menopause experienced decreased rates of breast cancer and death from the disease even after they stopped taking the therapy, when compared to women who took estrogen with progestin.

Partial Breast Irradiation Is Effective in Preventing Recurrence in Patients with Early-Stage Breast Cancer

Partial Breast Irradiation Is Effective in Preventing Recurrence in Patients with Early-Stage Breast Cancer

December 13th 2019, 10:00pm

SABCS

Survival and recurrence rates were similar among patients with breast cancer who either received accelerated partial breast irradiation or whole breast irradiation.

Awareness for Men With Breast Cancer is Starting to Take Hold at Major Conferences

Awareness for Men With Breast Cancer is Starting to Take Hold at Major Conferences

December 13th 2019, 9:00pm

SABCS

This massive event for women with breast cancer just may be “man’s breast friend”.

Arimidex Extends Benefit of Breast Cancer Recurrence Prevention in Postmenopausal Women

Arimidex Extends Benefit of Breast Cancer Recurrence Prevention in Postmenopausal Women

December 13th 2019, 3:00am

SABCS

Women treated with Arimidex for five years were 50% less likely to have developed breast cancer recurrence compared with women given placebo at nearly 11 years follow-up after stopping treatment.

Adding Immunotherapy to Chemo Before Surgery May Not Improve Response Rates in TNBC

Adding Immunotherapy to Chemo Before Surgery May Not Improve Response Rates in TNBC

December 13th 2019, 12:41am

SABCS

Adding Tecentriq to chemotherapy before surgery did not improve the rate of pathologic complete response in patients with advanced, early-stage triple-negative breast cancer.